Bausch & Lomb (BLCO) EBT (2021 - 2026)

Bausch & Lomb (BLCO) has reported EBT for 6 consecutive years, with -$11.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 92.52% year-over-year to -$11.0 million; the trailing twelve-month figure through Jun 2026 stood at -$65.0 million (up 83.54% YoY), and the FY2025 full-year result was -$317.0 million, down 35.47% from the prior year.
• EBT climbed to -$11.0 million in Q2 2026 per BLCO's latest filing, from -$64.0 million in the prior quarter.
• Across five years, EBT topped out at $29.0 million in Q1 2022 and bottomed at -$180.0 million in Q1 2025.
• Historically, EBT has averaged -$39.9 million across 5 years, with a median of -$27.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: EBT sank 2750.0% in 2023, then jumped 230.0% in 2025.
• Over 5 years, EBT stood at -$2.0 million in 2022, then tumbled by 2750.0% to -$57.0 million in 2023, then surged by 82.46% to -$10.0 million in 2024, then surged by 230.0% to $13.0 million in 2025, then tumbled by 184.62% to -$11.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$11.0 million, -$64.0 million, and $13.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.